REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 205 filers reported holding REGENXBIO INC in Q3 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,157,000 | -31.5% | 63,250 | -8.9% | 0.00% | 0.0% |
| Q4 2020 | $3,148,000 | +61.4% | 69,400 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $1,951,000 | -23.1% | 70,900 | +2.9% | 0.00% | -33.3% |
| Q2 2020 | $2,538,000 | +15.3% | 68,900 | +1.3% | 0.00% | 0.0% |
| Q1 2020 | $2,202,000 | -25.3% | 68,000 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $2,946,000 | +30.8% | 71,900 | +13.6% | 0.00% | +50.0% |
| Q3 2019 | $2,253,000 | +101.5% | 63,300 | +190.9% | 0.00% | +100.0% |
| Q2 2019 | $1,118,000 | -31.2% | 21,757 | -23.2% | 0.00% | -50.0% |
| Q1 2019 | $1,624,000 | +35.7% | 28,343 | -0.7% | 0.00% | 0.0% |
| Q4 2018 | $1,197,000 | -46.7% | 28,543 | -4.0% | 0.00% | -33.3% |
| Q3 2018 | $2,246,000 | +55.4% | 29,743 | +47.7% | 0.00% | +50.0% |
| Q2 2018 | $1,445,000 | – | 20,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
| Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
| MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
| ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
| Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
| WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
| Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
| SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |